Synthesis, DNA-Binding, Anticancer Evaluation, and Molecular Docking Studies of Bishomoleptic and Trisheteroleptic Ru-Diimine Complexes Bearing 2-(2-Pyridyl)-quinoxaline

<table class="table-group" id="tab9"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td class="align_left">Atoms that participate</td><td class="align_left">Distances</td><td class="align_left">Energy</td><td class="align_left"> </td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td class="align_left">A : DG67 : 21 and N of quinoxaline</td><td class="align_center">1.783</td><td class="align_center">7.683</td><td class="align_center">1</td></tr><tr><td class="align_left"> </td><td class="align_center">—</td><td class="align_center">—</td><td class="align_center">2</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Molecular docking studies for 1 and 2 with the sequence (ACCGACGTCGGT)<sub>2</sub> (pdb code: 423D).</div>

Bioinorganic Chemistry and Applications

tab9

Table 9

Table 9: Synthesis, DNA-Binding, Anticancer Evaluation, and Molecular Docking Studies of Bishomoleptic and Trisheteroleptic Ru-Diimine Complexes Bearing 2-(2-Pyridyl)-quinoxaline 

Table 9 | Synthesis, DNA-Binding, Anticancer Evaluation, and Molecular Docking Studies of Bishomoleptic and Trisheteroleptic Ru-Diimine Complexes Bearing 2-(2-Pyridyl)-quinoxaline 